2-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid

Ref. TR-C183530

Informations sur le produit

• Nom: 2-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid
• Synonymes: Carfilzomib Impurity 1 (Mixture of Diastereomers)

Description

Applications 2-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid is an impurity of Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 912.033
• Formule: C₄₆H₆₅N₅O₁₄
• Couleur/Forme: White To Off-White
• InChI: InChI=1S/C46H65N5O14/c1-29(2)22-34(40(56)45(5,62)28-65-39(55)26-46(63,44(60)61)25-38(53)54)48-43(59)36(24-32-14-10-7-11-15-32)50-42(58)35(23-30(3)4)49-41(57)33(17-16-31-12-8-6-9-13-31)47-37(52)27-51-18-20-64-21-19-51/h6-15,29-30,33-36,62-63H,16-28H2,1-5H3,(H,47,52)(H,48,59)(H,49,57)(H,50,58)(H,53,54)(H,60,61)/t33-,34-,35-,36-,45+,46?/m0/s1
• Code InChI: InChIKey=LMLWWAPDCPJQKV-WBIBXKIUSA-N
• SMILES: CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@](C)(O)COC(=O)CC(O)(CC(=O)O)C(=O)O